Avalara Announces Pricing of Initial Public Offering


SEATTLE–(BUSINESS WIRE)–Avalara, Inc. (NYSE: AVLR) today announced the pricing of its initial
public offering of 7,500,000 shares of its common stock at a public
offering price of $24.00 per share.

The shares are expected to begin trading on the New York Stock Exchange
on June 15, 2018, under the symbol “AVLR,” and the offering is expected
to close on June 19, 2018, subject to customary closing conditions.
Avalara has granted the underwriters a 30-day option to purchase up to
an additional 1,125,000 shares of common stock to cover over-allotments,
if any.

Goldman Sachs & Co. LLC, J.P. Morgan, and BofA Merrill Lynch are acting
as book-running managers for the offering. JMP Securities, KeyBanc
Capital Markets, and Stifel are acting as co-managers.

The offering is being made only by means of a prospectus. Copies of the
final prospectus related to the offering, when available, may be
obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West
Street, New York, NY 10282, or by telephone at 866-471-2526, or by email
at prospectus-ny@ny.email.gs.com,
or from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at
866-803-9204, or email at prospectus-eq_fi@jpmchase.com.
A registration statement relating to these securities has been filed
with, and declared effective by, the Securities and Exchange Commission.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or


Investor Contact
Kevin Faulkner, 206-641-2425

Jesse Hamlin, 518-281-0631

Do you think you can beat this Sweet post?

If so, you may have what it takes to become a Sweetcode contributor... Learn More.


Click on a tab to select how you'd like to leave your comment

Leave a Comment

Your email address will not be published. Required fields are marked *